FY22 Annual Report
Filed with ASX · · 82 pages · English
On 6ix: 6ix.com/news/fy22-annual-report
Lumos Diagnostics Holdings Ltd. on 6ix
In the deck
Story so far
Earlier from Lumos Diagnostics
- FY22 Appendix 4E
- Lumos Pilot Manufacturing to Commence in Carlsbad
- Lumos Withdraws from Local Manufacturing Proposal
- Lumos Files Appeal To The FDA For FebriDx
- Lumos To Close Sarasota Facility
Later from Lumos Diagnostics
- FY22 Full Year Results Investor Presentation
- FY22 Full Year Results Media Release
- Outcome of Appeal to FDA for FebriDx
- Lumos Completes Closure of Sarasota Facility
- Publication of Data from DISRUPT Clinical Trial in JAMA
Follow Lumos Diagnostics into a list and get an email when it puts out news.
Follow Lumos Diagnostics